This formulation of the Pfizer COVID-19 vaccine is for those ages 12 years and above.
The vaccine will be given as an injection into the muscle, usually your deltoid (shoulder) muscle.
For the primary series, which means you’ve never received a COVID-19 vaccine before, you will need 2 doses, at least 3 weeks apart. A third primary series dose may be administered at least 28 days after the second dose to individuals who are determined to have certain kinds of immunocompromise.
The Pfizer COVID-19 vaccine that MD Now offers is FDA-approved for ages 16 and older in the U.S., and Emergency Use Authorized for ages 12-15. The Pfizer COVID-19 vaccine remains Emergency Use Authorization (EUA) approved for ages 5-15. The Pfizer vaccine we offer at our clinics is for ages 12 and above.
Individuals should not get this vaccine if they’ve had a severe allergic reaction after a previous dose of this vaccine or had a severe allergic reaction to any ingredient of this vaccine.
There is a remote chance that the vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to 1 hour after getting a dose of the vaccine. For this reason, vaccination providers may ask individuals to stay at the place where they received the vaccine for monitoring after vaccination. The signs of a severe allergic reaction can include difficulty breathing, swelling of the face and throat, a fast heartbeat, a bad rash all over the body, dizziness, and weakness. If you are ever experiencing a severe allergic reaction, you or someone should call 9-1-1 or go to the nearest hospital.
Additional side effects that have been reported with the vaccine include: severe allergic reactions; non-severe allergic reactions such as rash, itching, hives, or swelling of the face; myocarditis (inflammation of the heart muscle); pericarditis (inflammation of the lining outside the heart); injection site pain; tiredness; headache; muscle pain; chills; joint pain; fever; injection site swelling; injection site redness; nausea; feeling unwell; swollen lymph nodes (lymphadenopathy); decreased appetite; diarrhea; vomiting; arm pain; fainting in association with injection of the vaccine.
These may not be all the possible side effects of the vaccine. Serious and unexpected side effects may occur. The possible side effects of the vaccine are still being studied in clinical trials. Call the vaccination provider or healthcare provider about bothersome side effects that do not go away.
Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received the vaccine, more commonly in males under 40 years of age than among females and older males. In most of these people, symptoms began within a few days following receipt of the second dose of the vaccine. The chance of having this occur is very low. Individuals should seek medical attention right away if they have any of the following symptoms after receiving the vaccine: chest pain, shortness of breath, or you are feeling a fast-beating, fluttering, or pounding heart.
According to the FDA, “During a public health emergency, the FDA can use its Emergency Use Authorization (EUA) authority to allow the use of unapproved medical products, or unapproved uses of approved medical products, to diagnose, treat, or prevent serious or life-threatening diseases when certain criteria are met, including that there are no adequate, approved, and available alternatives.”
According to the Emergency Use Authorization, individuals with moderately or severely immunocompromising conditions may receive an additional primary dose of vaccine 28 days after their second primary series dose. The third dose may still not provide full immunity to COVID-19 in people who are immunocompromised, and you should continue to maintain physical precautions to help prevent COVID-19. In addition, your close contacts should be vaccinated as appropriate.
When prepared according to their respective instructions for use, the FDA-approved COMIRNATY® ( COVID-19 Vaccine, mRNA) and the Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older (purple cap and gray cap) can be used interchangeably without presenting any safety or effectiveness concerns.
Of note, individuals 5 through 11 years can only receive the FDA-authorized Pfizer-BioNTech COVID-19 Vaccine formulation identifiable with an orange cap.
No. The vaccine does not contain SARS-CoV-2 and cannot give you COVID-19.
The vaccine in the gray cap includes the following ingredients: mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3-phosphocholine, and cholesterol), tromethamine, tromethamine hydrochloride, and sucrose.
No, the vaccine does not contain preservative.
The vial stoppers are not made with natural rubber latex.
Yes, Pfizer has ensured that underrepresented populations participate in all their studies by recruiting people who fully represent the racial and ethnic diversity of their communities.
For more information about COVID-19 vaccination, please visit the CDC website.
A booster shot is strongly encouraged to increase your immunity and decrease your risk of serious COVID-related illness and hospitalization.
A single booster dose of the vaccine may be administered to individuals 12 years of age and older who have completed primary vaccination with a different authorized COVID-19 vaccine. Individuals should check with their healthcare provider regarding timing of the booster dose.
A single booster dose of the Pfizer vaccine may be administered at least 5 months after completion of a primary series of the Pfizer-BioNTech COVID-19 Vaccine or COMIRNATY® (COVID-19 Vaccine, mRNA) to individuals 12 years of age and older.
Yes, MD Now offers the second booster dose of the Pfizer-BioNTech COVID-19 Vaccine for those who are eligible to receive it.
The second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may also be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise.
Everyone waiting on the arrival of vaccine booster shots could stop holding their breath in mid-November 2021. The CDC expanded eligibility for COVID-19 booster shots to all adults on November 19. Before you search, “booster shots near me,” take a minute to learn the ins and outs of enhancing your protection against COVID-19. The FDA Announcement: It’s Time for a Boost Per the current recommendations,… Read More
Vaccines are a hot topic right now. With many rumors circulating, it can be difficult to access accurate information. The good news is that current data shows the approved vaccines are safe for most people. There are numerous benefits that come with vaccination. In fact, it's the best way to ensure we get back to normal quickly. The Benefits of the COVID-19 Vaccine Travel Some countries are making vaccination… Read More
You might be wondering, “Should I get the COVID-19 vaccine?” It’s natural to feel apprehensive about potential COVID-19 vaccine side effects, especially with so many rumors floating around the internet. MD Now is here to address your concerns about the vaccines and set your mind at ease. The COVID-19 Vaccine Benefits: How Vaccination Can Save Lives Vaccines train our immune systems to recognize and fight… Read More
Online check-ins are a great way to let us know you are on your way. We will do our best to see you at your check in time, but patients with more emergent needs will require immediate treatment.